Integrated bulk and single-cell transcriptomes reveal pyroptotic signature in prognosis and therapeutic options of hepatocellular carcinoma by combining deep learning

被引:6
作者
Liu, Yang [1 ]
Li, Hanlin [1 ]
Zeng, Tianyu [1 ]
Wang, Yang [1 ]
Zhang, Hongqi [2 ]
Wan, Ying [1 ]
Shi, Zheng [3 ,4 ]
Cao, Renzhi [5 ]
Tang, Hua [1 ,6 ]
机构
[1] Southwest Med Univ, Sch Basic Med Sci, Luzhou, Peoples R China
[2] Univ Elect Sci & Technol China, Ctr Informat Biol, Sch Life Sci & Technol, Chengdu, Peoples R China
[3] Chengdu Univ, Clin Med Coll, Clin Genet Lab, Chengdu 610106, Peoples R China
[4] Chengdu Univ, Affiliated Hosp, Chengdu 610106, Peoples R China
[5] Pacific Lutheran Univ, Dept Comp Sci, Tacoma, WA 98447 USA
[6] Minist Educ, Basic Med Res Innovat Ctr Cardiometab Dis, Luzhou 646000, Peoples R China
基金
中国国家自然科学基金;
关键词
pyroptosis; hepatocellular carcinoma; attention mechanism; tumor microenvironment; scRNA-seq; precision medicine; CANCER; TUMORIGENESIS; EXPRESSION; DIVERSITY; STEMNESS; PATHWAY; GROWTH; AXIS; YAP;
D O I
10.1093/bib/bbad487
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Although some pyroptosis-related (PR) prognostic models for cancers have been reported, pyroptosis-based features have not been fully discovered at the single-cell level in hepatocellular carcinoma (HCC). In this study, by deeply integrating single-cell and bulk transcriptome data, we systematically investigated significance of the shared pyroptotic signature at both single-cell and bulk levels in HCC prognosis. Based on the pyroptotic signature, a robust PR risk system was constructed to quantify the prognostic risk of individual patient. To further verify capacity of the pyroptotic signature on predicting patients' prognosis, an attention mechanism-based deep neural network classification model was constructed. The mechanisms of prognostic difference in the patients with distinct PR risk were dissected on tumor stemness, cancer pathways, transcriptional regulation, immune infiltration and cell communications. A nomogram model combining PR risk with clinicopathologic data was constructed to evaluate the prognosis of individual patients in clinic. The PR risk could also evaluate therapeutic response to neoadjuvant therapies in HCC patients. In conclusion, the constructed PR risk system enables a comprehensive assessment of tumor microenvironment characteristics, accurate prognosis prediction and rational therapeutic options in HCC.
引用
收藏
页数:15
相关论文
共 47 条
  • [1] Aibar S, 2017, NAT METHODS, V14, P1083, DOI [10.1038/NMETH.4463, 10.1038/nmeth.4463]
  • [2] Alvarez Mariano, 2021, Bioconductor, DOI 10.18129/B9.BIOC.GENOMICINSTABILITY
  • [3] Inflammation and cancer: back to Virchow?
    Balkwill, F
    Mantovani, A
    [J]. LANCET, 2001, 357 (9255) : 539 - 545
  • [4] Molecular and histological correlations in liver cancer
    Calderaro, Julien
    Ziol, Marianne
    Paradis, Valerie
    Zucman-Rossi, Jessica
    [J]. JOURNAL OF HEPATOLOGY, 2019, 71 (03) : 616 - 630
  • [5] Therapeutic modulation of inflammasome pathways
    Chauhan, Dhruv
    Vande Walle, Lieselotte
    Lamkanfi, Mohamed
    [J]. IMMUNOLOGICAL REVIEWS, 2020, 297 (01) : 123 - 138
  • [6] MiR-137 Suppresses Triple-Negative Breast Cancer Stemness and Tumorigenesis by Perturbing BCL11A-DNMT1 Interaction
    Chen, Feiyu
    Luo, Na
    Hu, Yu
    Li, Xin
    Zhang, Kejing
    [J]. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 47 (05) : 2147 - 2158
  • [7] Signature Construction and Molecular Subtype Identification Based on Pyroptosis-Related Genes for Better Prediction of Prognosis in Hepatocellular Carcinoma
    Chen, Ji
    Tao, Qiqi
    Lang, Zhichao
    Gao, Yuxiang
    Jin, Yan
    Li, Xiaoqi
    Wang, Yajing
    Zhang, Yuxiao
    Yu, Suhui
    Lv, Boyu
    Yu, Zhengping
    Lin, Changyong
    [J]. OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2022, 2022
  • [8] Computational Methods for Identifying Similar Diseases
    Cheng, Liang
    Zhao, Hengqiang
    Wang, Pingping
    Zhou, Wenyang
    Luo, Meng
    Li, Tianxin
    Han, Junwei
    Liu, Shulin
    Jiang, Qinghua
    [J]. MOLECULAR THERAPY-NUCLEIC ACIDS, 2019, 18 : 590 - 604
  • [9] Cell type and gene expression deconvolution with BayesPrism enables Bayesian integrative analysis across bulk and single-cell RNA sequencing in oncology
    Chu, Tinyi
    Wang, Zhong
    Pe'er, Dana
    Danko, Charles G.
    [J]. NATURE CANCER, 2022, 3 (04) : 505 - +
  • [10] Tumour heterogeneity and resistance to cancer therapies
    Dagogo-Jack, Ibiayi
    Shaw, Alice T.
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2018, 15 (02) : 81 - 94